Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage
NEJM 390:1745-1755, 1815, Connolly,S.J.,et al, 2024
Thrombolysis After Dabigatran Reversal for Acute Ischemic Stroke
Neurol 103:e209862, Theodorou,A.,et al, 2024
Administering Thrombolysis for Acute Ischemic Stroke in Patients Taking Direct Oral Anticoagulants
JAMA Neurol 78:515-518, Seiffge, D.J.,et al, 2021
Dabigatran Reversal Before Intravenous Tenecteplase in Acute Ischemic Stroke
Stroke 51:1616-1619, Beharry, J.,et al, 2020
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA
NEJM 379:215-225, 291, Johnston, S.C.,et al, 2018
Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation
NEJM 376:1627-1636, Calkins, H.,et al, 2017
Treatment and Outcome of Hemorrhagic Transformation after Intravenous Alteplase in Acute Ischemic Stroke
Stroke 48:e343-e361, Yaghi, S.,et al, 2017
Polycythemia Vera Presenting with Ischemic Strokes in Multiple Arterial Territories
Neurol 82:e168-e170, Billakota, S. & Husseini, N.E., 2014
Summary of Evidence-Based Guideline: Periprocedural Management of Antithrombic Medications in Patients with Ischemic Cerebrovascular Disease
Neurol 80:2065-2069, Armstrong, M.,et al, 2013
Edoxaban Versus Warfarin in Patients with Atrial Fibrillation
NEJM 369:2093-2104, Giugliano, R.P.,et al, 2013
Using Dabigatran in Patients with Stroke A Practical Guide for Clinicians
Stroke 43:271-279, Alberts, M.J.,et al, 2012
Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomized controlled trial
Lancet 380:1749-1758, Lopes, R.,et al, 2012
Apixaban in Patients With Atrial Fibrillation
NEJM 364:806-817, Connolly,S.J.,et al, 2011
Apixaban versus Warfarin in Patients with Atrial Fibrillation
NEJM 365:981-992,1052, Granger, C.B.,et al, 2011
Epidemiology, Pathogenesis, Clinical Manifestations and Diagnosis of Waldenstrom Macroglobulinemia
UptoDate, May, Rajkumar, S.V., 2011
Effect of Home Testing of International Normalized Ratio on Clinical Events
NEJM 363:1608-1620, Matchar,D.B.,et al, 2010
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
NEJM 360:2066-2078,2127, The ACTIVE Investigators, 2009
Does the Combination of Warfarin and Aspirin Have a Place in Secondary Stroke Prevention? No
Stroke 40:1944-1945,1946, Fisher,M., 2009
Brain Lesions Are Most Often Reversible in Acute Thrombotic Thrombocytopenic Purpura
Neurol 73:66-70, Burrus,T.M.,et al, 2009
Risk of Thromboembolic Events in Controlled Trials of rFVIIa in Spontaneous Intracerebral Hemorrhage
Stroke 39:850-856, Diringer,M.N.,et al, 2008
Ischemic Stroke and ICU Care
Semin Neurol 28:645-656, Llinas, R, 2008
Combining Aspirin With Oral Anticoagulant Therapy: Is This a Safe and Effective Practice in Patients With Atrial Fibrillation?
Stroke 38:1652-1654, Gorelick,P.B., 2007
Multiple Ischemic Strokes Associated With Use of Recombinant Activated Factor VII
Arch Neurol 64:879-881, Libman,R.B.,et al, 2007
Thromboembolic Adverse Events After Use of Recombinant Human Coagulation Factor VIIa
JAMA 295:293-298, OConnell,K.A.,et al, 2006
Clopidogrel Plus Aspirin Versus Oral Anticoagulation for Atrial Fibrillation in the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events (ACTIVE W): A Randomised Controlled Trial
Lancet 367:1903-1912,1877, The ACTIVE Writing Group on behalf of the ACTIVE Investigators, 2006
Effects of Reviparin, a Low-Molecular-Weight Heparin, on Mortality, Reinfarction, and Strokes in Patients With Acute Myocardial Infarction Presenting With ST-Segment Elevation
JAMA 293:427-436, The CREATE Trial Group Investigators, 2005
Aspriin and Clopidogrel Compared with Colpidogrel Alone After Recent Ischaemic Stroke or Transient Ischaemic Attack in High-Risk Patients (MATCH): Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 364:331-337, Diener,H.-C.,et al, 2004
Stroke Risk in Anticoagulated Patients with Atrial Fibrillation Undergoing Endoscopy
Neurol 61:964-968, Blacker,D.J.,et al, 2003
Safety of Intra-Arterial Thrombolysis in the Postoperative Period
Stroke 32:1365-1369, Chalela,J.A.,et al, 2001
Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes Without St-Segment Elevation
NEJM 345:494-502, The Clopidogrel in Unstable Angina to Prevent Recu, 2001
Neurology and the Blood:Haematological Abnormalities in Ischaemic Stroke
JNNP 64:150-159, Markus,H.S.&Hambley,H., 1998
Ischemic Stroke as First Manifestation of Essential Thrombocythemia, Report of Six Cases
Stroke 26:1463-1466, Arboix,A.,et al, 1995
Ticlopidine
Editorial, Lancet 337:459-4601991., , 1991
Cerebral Infarction in Young People, A Study of 148 Patients with Early Cerebral Angiography
JNNP 54:576-579, Lisovoski,F.&Rousseaux,P., 1991
Hematologic Disorders and Ischemic Stroke
Stroke 21:1111-1121, Hart,R.G.&Kanter,M.C., 1990
Combination Therapy with Low-Dose Aspirin and Ticlopidine in Cerebral Ischemia
Stroke 20:1643-1647, Uchiyama,S.,et al, 1989
Nonhemorrhagic Cerebral Infarction in Young Adults
Arch Neurol 43:793-796, Adams,H.P.,et al, 1986
Cerebrovascular Disorders Associated with Pregnancy
Jr, AFP 33:125-1321986., Biller,J.&Adams,H.P., 1986
Neurologic Complications of Disseminated Intravascular Coagulation
Neurol 32:791-797, Schwartzman,R.J.,et al, 1982
Neurologic Manifestations in Macroglobulinemia
In Vinken PJ, Bruyn GW, Eds, Handbook of Clin Neurol, Vol 39, North-Holland Publ Co, p. 189, Abramsky,O., 1980
Nonatherosclerotic Causes of Stroke
Ann Int Med 70:807, Levine,J.,et al, 1969
Neurologic Syndrome Associated With Primary Thrombocythemia
J Mt Siami Hosp 36:317-323, Korenman,G., 1969
Neurologic Complications of Polycythemia
Ann Int Med 57:909, Silverstein,A.,et al, 1962